Uterine sarcomas and parasitic myomas after laparoscopic hysterectomy with power morcellation

Objective The purpose of this study was to describe the incidence and risk factors for uterine sarcomas and parasitic myomas at the time of power morcellation. Study Design We performed a retrospective review of 3523 women who underwent laparoscopic hysterectomy from 2001-2012. Univariate analyses w...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of obstetrics and gynecology 2015-05, Vol.212 (5), p.594.e1-594.e10
Hauptverfasser: Tan-Kim, Jasmine, MD, MAS, Hartzell, Katherine A., MD, Reinsch, Caryl S., MD, O’Day, Cristina H., MD, Kennedy, John S., MD, Menefee, Shawn A., MD, Harrison, Terry A., MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objective The purpose of this study was to describe the incidence and risk factors for uterine sarcomas and parasitic myomas at the time of power morcellation. Study Design We performed a retrospective review of 3523 women who underwent laparoscopic hysterectomy from 2001-2012. Univariate analyses were used for the morcellation cases to identify potential risk factors. Multivariable logistic regression was performed. Results Nine hundred forty-one patients underwent power morcellation at the time of hysterectomy; 10 of 941 patients (1.1%) were diagnosed subsequently with uterine sarcomas or parasitic myomas. The overall incidence of uterine sarcoma was 6 of 941 (0.6%), with a median age of 47 years (range, 41–52 years). There was no association among any of the factors analyzed and uterine sarcoma. Three of 6 patients had sarcoma diagnosed on initial pathologic evaluation of the morcellated specimen; 3 patients had delayed diagnosis of sarcoma with benign disease at the time of the initial procedure (median time to second evaluation, 6 years). For parasitic myomas (n = 4), the median age was 35 years (range, 32–40 years), and the median time to second evaluation was 5 years. On multivariate analysis, age
ISSN:0002-9378
1097-6868
DOI:10.1016/j.ajog.2014.12.002